Jessica Sachs
Technik-/Wissenschafts-/F&E-Leiter bei COGENT BIOSCIENCES, INC.
Vermögen: 7 789 $ am 30.04.2024
Aktive Positionen von Jessica Sachs
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| COGENT BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2019 | - |
| Corporate Officer/Principal | 01.04.2017 | 01.06.2019 |
Karriereverlauf von Jessica Sachs
Ehemalige bekannte Positionen von Jessica Sachs
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01.01.2012 | 01.04.2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2010 | 01.01.2012 |
Ausbildung von Jessica Sachs
| Duke University | Undergraduate Degree |
| Washington University in St. Louis | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Japan | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Jessica Sachs
- Erfahrung
